<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03166774</url>
  </required_header>
  <id_info>
    <org_study_id>AssO</org_study_id>
    <nct_id>NCT03166774</nct_id>
  </id_info>
  <brief_title>Support of the Sexual Health in Oncology</brief_title>
  <official_title>Support of the Sexual Health in Oncology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Implementation of sexual health support program in oncology department. This program is
      organized in 3 axes. One is to inform the side effects of treatment on sexual health.

      There is a counselling team (nurse, esthetician,sexologue..etc) to raise the subject with
      patient and partner .

      Finally, the oncologist continue during the treatment to evaluate the benefit of this program
      and adapt their counselling according to the needs
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    The study stopped because the the project was abandoned.
  </why_stopped>
  <start_date type="Actual">June 6, 2016</start_date>
  <completion_date type="Anticipated">June 6, 2017</completion_date>
  <primary_completion_date type="Actual">June 6, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Benefit of the care measurement program</measure>
    <time_frame>Day 1</time_frame>
    <description>assessment of data recorded on questionnaire</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">0</enrollment>
  <condition>Oncology</condition>
  <condition>Sexual Health</condition>
  <arm_group>
    <arm_group_label>patient consulting in oncology ervice</arm_group_label>
    <description>Program of support of the sexual health in oncology by questionnaire</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Program of support of the sexual health</intervention_name>
    <description>Patients included in the study have to answer to a questionnaire</description>
    <arm_group_label>patient consulting in oncology ervice</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient followed in oncology
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patient consulting in oncology service

          -  age &gt; 18 years

          -  accepting to participate

        Exclusion Criteria:

          -  Age&lt; 18 years

          -  Refusing to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandra SCHULTZ, Psychologist</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Paris Saint Joseph</affiliation>
  </overall_official>
  <removed_countries>
    <country>France</country>
  </removed_countries>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>May 24, 2017</study_first_submitted>
  <study_first_submitted_qc>May 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 25, 2017</study_first_posted>
  <last_update_submitted>August 8, 2018</last_update_submitted>
  <last_update_submitted_qc>August 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

